Biology of CD34⁺CD38^- Cells in Lymphohematopoiesis

References

• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J Immunol 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K., Civin C. I. Flow Cytometric Analysis of Human Bone Marrow: I. Normal Erythroid Development. Blood 1987; 69: 255–263
   PubMed Web of Science ®Google Scholar
• Civin C. I. Human monomyeloid cell membrane antigens. Exp Hematol 1990; 18: 461–7
   PubMed Web of Science ®Google Scholar
• Debili N., Coulombel L., Croisille L., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Characterization of bipotent erythroid-megakaryocytic progenitor in human bone marrow. Blood 1996; 88: 1284–1296
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316–24
   PubMed Web of Science ®Google Scholar
• Spitz H., Lanier L. L., Phillips J. H. Development of human T and natural killer cells. Blood 1995; 85: 2654–267
   PubMed Web of Science ®Google Scholar
• Krause D. S., Fackler M. J., Civin C. I., May W. S. CD34: Structure, Biology, and Clinical Utility. Blood 1996; 87: 1–13
   PubMed Web of Science ®Google Scholar
• Enson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C D., Bernstein I. D., et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–22
   PubMed Web of Science ®Google Scholar
• Civin C. I., Trischmann T., Kadan N. S., Davis J., Noga S., Cohen K., Duffy B., Groenewegen I., Wiley J., Law P., Hardwick A., Oldham F., Gee A. Highly Purified CD34+ Cells Reconstitute Hematopoiesis. Clin. Oncol. 1996; 14: 2224–2233
   Web of Science ®Google Scholar
• Sprangrude G. J., Heimfeld S., Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58–62
   PubMed Web of Science ®Google Scholar
• Jones R. J., Collector M. I., Barber J. P., Vala M. S., Fackler M. J., May W. S., Griffin C. A., Hawkins A. L., Zehnbauer B. A., Hilton J., Colvin O. M., Sharkis S. J. Characterization of Mouse Lymphohematopoietic Stem Cells Lacking Spleen Colony-Forming Activity. Blood 1996; 88: 487–491
   PubMed Web of Science ®Google Scholar
• Mc Culloch E. A. Control of hematopoiesis at the cellular level. Regulation of Hematopoiesis. G.A.S., New York, NY 1970; 133, Appleton
   Google Scholar
• Terstappen L. W.M.M., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+ CD38- progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Kung P C, Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. 1980; 11: 1588–1592
   Web of Science ®Google Scholar
• Alessio M., Roggero S., Funaro A., De Monte L. B., Peruzzi L., Geuna M., Malavasi F. CD38 molecule: structural and biochemival analysis on human lymphocytes, thymocytes, and plasma cells. J. Immunol 1990; 145: 878–884
   PubMed Web of Science ®Google Scholar
• Nagler A., Lanier L. L., Cwirla S., Phillips J. H. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1990; 143: 3183–3191
   Web of Science ®Google Scholar
• Terhorst C., Van Aghtoven A., Le Clair K., Snow P., Reinherz E., Schlossman S. Biochemical studies of the human thymocyte on cell-surface antigens T6, T9 and T10. Cell 1981; 23: 771–780
   PubMed Web of Science ®Google Scholar
• Terstappen L. W.M.M., Hollander Z., Meiners H., Loken M. R. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J. Leukocyte Biol. 1990; 48: 139–148
   Web of Science ®Google Scholar
• Sieff C., Bicknell D., Calne G., Robinson J., Lam G., Greaves M. F. Changes in cell surface anitgen expression during hematopoietic differentiation. Blood 1982; 60: 703–713
   PubMed Web of Science ®Google Scholar
• Zocchi E., Franco L., Guida L., Benatti U., Bargellesi A., Malavasi F., Lee H. C., Deflora A. Single protein immunologically identified as CD38 displays NAD+A glycohydrolase and cyclic ADP-ribose hydrolase acitivities as the outer surface of human erythrocytes. Biochem. Biophys. Res. Commun. 1993; 196: 1459–1465
   PubMed Web of Science ®Google Scholar
• Ramaschi G., Torti M., Festetics E. R., Sinigaglia F., Malavasi F., Balduini C. Expression of cyclic ADP-ribose-synthetizing CD38 molecule on human platelet membrane. Blood 1996; 87: 2308–2313
   PubMed Web of Science ®Google Scholar
• Galibert L., Burdin N., De-Saint-Vis B., Garrone P., Van Kooten C., Banchereau J., Rousset F. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J, Exp. Med. 1996; 183: 77–85
   PubMed Web of Science ®Google Scholar
• Kontani K., Nishina H., Ohoka Y., Takahashi K., Katada T. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells: identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J. Biol. Chem. 1993; 268: 16895–16898
   PubMed Web of Science ®Google Scholar
• Drach J., Zhao S., Malavasi F., Mehta K. Rapid induction of CD38 antigen on myeloid leukemia cells by all-trans retinoic acidq. Biochem. Biophys. Res. Commun. 1993; 195: 545–550
   PubMed Web of Science ®Google Scholar
• Ho H. N., Hultin L. E., Mitsuyasu R. T., Matud J. L., Hausner M. A., Bockstoce D., Chou C. C., O'Rourke S., Taylor J. M.G., Giorgi J. V. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol. 1993; 150: 3070–3079
   PubMed Web of Science ®Google Scholar
• Oliver A. M., Martin F., Kearney J. F. Mouse CD38 is downregulated on germinal center B cells and mature plasma cells. J. Immunol 1997; 158: 1108–1115
   PubMed Web of Science ®Google Scholar
• Bean A. G.D., Godfrey D. E., Ferlin W. G., Santos-Argumedo L., Parkhouse M. R., Howard M. C., Zlotnik A. CD38 expression on mouse T cells: CD38 define functionally distinct subsets of alpha-beta TCR+CD4_CD38- thymocytes. Int. Immunol 1995; 7: 213–221
   PubMed Web of Science ®Google Scholar
• Randall T. D., Lund F. E., Howard M. C., Weissman I. L. Expression of murine CD38 defines a population of long-term breconstituting hematopoietic stem cells. Blood 1996; 87: 4057–4067
   PubMed Web of Science ®Google Scholar
• Harada N., Santos-Argumedo L., Chang R., Grimaldi J. G., Lund F. E., Brannan C. I., Copeland N. G., Jenkins N. A., Heath A. W., Parkhouse R. M.E., Howard M. Expression cloning of a cDNA encoding a novel murine B cell activation marker. J. Immunol 1993; 151: 3111–3118
   PubMed Web of Science ®Google Scholar
• Funaro A., Spagnoli G. C., Ausiello C., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol 1990; 145: 2390–2396
   PubMed Web of Science ®Google Scholar
• Santos-Argumedo L., Teixeira C., Preece G., Kirkham P. A., Parkhouse R. M.E. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J. Immunol 1993; 151: 3119–3130
   PubMed Web of Science ®Google Scholar
• Ausiello C M., Urbani R., Lasala A., Funaro A., Malavasi F. CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. Eur. J. Immunol 1995; 25: 1477–1480
   PubMed Web of Science ®Google Scholar
• Zupo S., Rugari E., Dono M., Taborelli G., Malavasi F., Ferrarini M. CD38 signaling by agonist monoclonal antibody prevents apoptosis of human germinal center B cells. Eur. J. Immunol 1994; 24: 1218–1222
   PubMed Web of Science ®Google Scholar
• Yamashita Y., Miyake K., Kikuchi Y., Takatsu K., Noda S., Kosugi A., Kimoto M. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-Iinked immunodeficient B cells. Immunology 1995; 85: 248–255
   PubMed Web of Science ®Google Scholar
• Zupo S., Isnardi L., Megna M., Massara R., Malavasi E., Dono M., Cosulich E., Ferrarini M. CD38 expression distinguishes two groups of B-cells chronic lymphocytic leukemias with different responses to Anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365–1374
   PubMed Web of Science ®Google Scholar
• Kumagai M., Coustan-Smith E., Murray D. J., Silven-Noined O., Gopal Murti K., Evans W. E., Malavasi F., Campana D. Ligation of CD38 suppresses human B lymphopoiesis. J. Exp. Med. 1995; 181: 1101–1110
   PubMed Web of Science ®Google Scholar
• Dianzani U., Funaro A., Difranco D., Garbarino G., Bragardo M., Redoglia V., Buonfiglio D., Demonte L., Piled A., Malavasi F. Interaction between endothelium and CD4+CD45RA+ lymphocytes: role of the human CD38 molecule. J. Immunol 1994; 154: 952–959
   Google Scholar
• Deaglio S., Dianzani U., Horenstein A. L., Fernandez J. E., Van Kooten C., Bragardo M., Funaro A., Garbarino G., Di Virgilio E., Banchereau J., Malavasi F. A 120-KDa protein predominantly expressed on endothelial cells. J. Immunol 1996; 156: 727–734
   PubMed Web of Science ®Google Scholar
• Howard M., Grimaldi J. C., Bazan J. F, Lund F. E., Santos-Argumedo L., Parkhouse R. M., Walseth T. F., Lee H. C. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocytic antigen CD38. Science 1993; 262: 1056–1059
   PubMed Web of Science ®Google Scholar
• Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., Yonekura H., Okamoto H. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol Chem. 1993; 268: 26052–26054
   PubMed Web of Science ®Google Scholar
• Summerhill R. J., Jackson D. J., Galione A. Human lymphocyte antigen CD38 catalyzed the production of cyclic ADP-ribose. FEBS Lett 1993; 335: 231–233
   PubMed Web of Science ®Google Scholar
• Grimaldi J. C., Balasubramanian S., Kabra N. H., Shanafelt A., Bazan J. F., Zurawski G., Howard M. C. CD38-mediated ribosylation of proteins. J. Immunol 1995; 155: 811–817
   PubMed Web of Science ®Google Scholar
• Hoshino S., Kukimoto I., Kontani K., Inoue S., Kanda Y., Malavasi F., Katada T. Mapping of the catalytic and epitopoic sites of human CD38/NAD+ glycohydrolase to a functional domain in the carboxyl terminus. J. Immunol 1997; 158: 741–747
   PubMed Web of Science ®Google Scholar
• Mehta K., Shahih U., Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 1996; 10: 1408–1417
   PubMed Web of Science ®Google Scholar
• Bernstein I. D., Andrews R. G., Zsebo K. M. Recombinant human stem cell factor enhances the formation of colonies by CD34 and CD34+lin- cells cultured with inter-leukin-3, granulocyte colony-stimulating factors, or granulocyte-macrophage colony-stimulating factor. Blood 1991; 11: 2316–2321
   Google Scholar
• Lansdorp P. M., Dragowska W. Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med 1992; 175: 1501–9
   PubMed Web of Science ®Google Scholar
• Craig W., Kay R., Cutler R. L. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 1993; 177: 1331–1342
   PubMed Web of Science ®Google Scholar
• Murray L., Chen B., Galy A., Chen S., Tushinski R., Uchida N., Negrin R., Tricot G., Jagannath S., Vedole D., Barlogie B., Hoffman R., Tsukamoto A. Enrichment of human hematopoietic stem cell activity in the CD34+Thyl+Lin- subpopulation from human mobilized peripheral blood. Blood 1995; 85: 368–378
   PubMed Web of Science ®Google Scholar
• Briddell R. A., Broudy V. C., Bruno E., Brandt J. E., Srour E. F., Hoffman R. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 1992; 79: 3159–67
   PubMed Web of Science ®Google Scholar
• Kawashima I., Zanjani E. D., Almeida-Porada G., Flake A. W., Zeng H., Ogawa M. CD34+ human marrow cells that express low levels of kit protein are enriched for long-term marrow-engrafting cells. Blood 1996; 87: 4136–4142
   PubMedGoogle Scholar
• Muench M. O., Roncarolo M. G., Rosnet O., Birnbaum D., Namikawa R. Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver. Exp. Hematol 1997; 25: 277–287
   PubMed Web of Science ®Google Scholar
• Roberts A. W., Zaiss M., Boyd A. W., Nicola N. A. G-CSF-mobilized peripheral blood progenitor cells: in vitro growth pattern and hematopoietic growth factor receptor profile. Exp. Hematol. 1997; 25: 298–305
   PubMed Web of Science ®Google Scholar
• Traycoff C M., Abboud M. R., Laver J., Brandt J. E., Hoffman R., Law P., Ishizawa L., Srour E. F. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp. Hematol 1994; 22: 215–222
   PubMed Web of Science ®Google Scholar
• Huang S., Terstappen L. W.M.M. Lymphoid and myeloid differentiation of single human CD34+ HLA-DR+ CD38- hematopoietic stem cells. Blood 1994; 83: 1515–1526
   PubMed Web of Science ®Google Scholar
• Apperley J. F. Meeting report: umbilical cord blood progenitor cell transplantation. Bone Marrow Transplant 1994; 14: 187–196
   PubMed Web of Science ®Google Scholar
• Srour E. F., Brandt J. E., Briddell R. A., Leemhuis T., Van Besien K., Hoffman R. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 1991; 17: 287–295
   PubMedGoogle Scholar
• Verfaillie C M., Miller W. J., Boylan K., McGlave P. B. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003–1010
   PubMed Web of Science ®Google Scholar
• Uchida N., Combs J., Chen S., Zanjani E., Hoffman R., Tsukamoto A. Primitive human hemopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 1996; 88: 1297–1305
   PubMed Web of Science ®Google Scholar
• Rusten L. S., Jacobsen S. E.W., Kaalhus O., Veiby O. P., Funderud S., Smeland E. B. Functional differences between CD38- and DR-subfractions of CD34+ bone marrow cells. Blood 1994; 84: 1473–1481
   PubMed Web of Science ®Google Scholar
• Cardoso A. A., Li M., Batard P., Hatzfeld A., Brown E. L., Levesque J., Sookdeo H., Panterne B., Sansilvestri P., Clark S. C., Hatzfeld I. Release from quiescence of CD34+CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl. Acad.Sci. USA 1993; 90: 8707–8711
   PubMed Web of Science ®Google Scholar
• De Bruyn C., Delforge A., Bron D., Bernier M., Massy M., Ley P., De Hemptinne D., Stryckmans P. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. Stem Cells 1995; 13: 281–288
   PubMed Web of Science ®Google Scholar
• Hao Q. L., Shah A. G., Thiemann F. T., Smogorzewska E. M., Crooks G. M. A functional comparison of CD34+CD38- cells in cord blood and bone marrow. Blood 1995; 86: 3745–3753
   PubMed Web of Science ®Google Scholar
• Hao Q. L., Thiemann F. T., Petersen D., Smogorzewska E. M., Crooks G. M. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996; 88: 3306–3313
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Giles R. E., Kavanagh J., Ellerson D., Zu Z., Wang T., Su Y., Kudelka A., Rahman Z., Holmes E., Hortobagyi G., Claxton D., Bachier C., Thall P., Cheng S., Hester J., Ostrove J. M., Bird R. E., Chang A., Korbling M., Seong D., Cote R., Holzmayer T., Mechetner E., Deisseroth A. B. Results of MDR-1 vector modification trial indicate that granulocyte/macriphage colony-forming unit cell do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc. Natl. Acad. Sci. 1996; 93: 15346–15351
   PubMed Web of Science ®Google Scholar
• Jordan C. T., Yamasaki G., Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp. Hematol 1996; 24: 1347–1355
   PubMed Web of Science ®Google Scholar
• Berardi A. C., Wang A., Levine J. D., Lopez P., Scadden D. T. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104–8
   PubMed Web of Science ®Google Scholar
• Orlic D., Bodine D. M. What defines a pluripotent hematopoietic stem cell (PHSC): Will the real PHSC please stand up!. Blood 1994; 84: 3991–3994
   PubMed Web of Science ®Google Scholar
• Srour E. F., Zanjani E. D., Cornetta K., Traycoff C M., Flake A. W., Hedrick M., Brandt J. E., Leemhuis T., Hoffman R. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 1993; 82: 3333–3342
   PubMed Web of Science ®Google Scholar
• Civin C. I., Almeida-Porada G., Lee M. J., Olweus J., Terstappen L. W.M.M., Zanjani E. D. Sustained, retransplantable, multilineage engraftments of highly purified adult bone marrow stem cells in vivo. Blood 1996; 88: 4102–4109
   PubMed Web of Science ®Google Scholar
• Ramirez M., Rottman G. A., Shultz L. D., Civin C. I. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp. Hematol 1997, In press
   Web of Science ®Google Scholar
• Larochelle A., Vormoor J., Hanenberg H., Wang J. C., Bhatia M., Lapidot T., Moritz T., Murdoch B., Xiao X. L., Kato I., Williams D. A., Dick I. E. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med. 1996; 2: 1329–1337
   PubMed Web of Science ®Google Scholar
• Hogan J. H., Shpall E. J., McNulty O., McNiece I., Dick J. E., Shultz L. D., Keller G. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 1: 85–96
   Google Scholar
• Lapidot T., Sirard C., Vormoor J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645–648
   PubMed Web of Science ®Google Scholar
• Lapidot T., Grunberger T., Vormoor J., Estrov Z., Kollet O., Bunin N., Zaizov R., Williams D. E., Freedman M. H. Identification of human juvenile myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 1996; 88: 2655–2664
   PubMed Web of Science ®Google Scholar
• Prince G. M., Nguyen M., Lazarus H. M., Brodsky R. A., Terstappen L. W.M.M., Medof M. E. Peripheral blood harvest of unaffected CD34+CD38- hematopoietic precursors in Paroxysmal Nocturnal Hemoglobinuria. Blood 1995; 86: 3381–3386
   PubMed Web of Science ®Google Scholar
• Turhan A. G., Lemoine F. M., Debert C., Bonnet M. L., Baillou C., Picard R., Macintyre E. A., Varet B. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. 1995; 85
   Google Scholar
• Bonnet D., Dick J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 1997; 3: 730–737
   PubMed Web of Science ®Google Scholar
• Lewis I. D., Haylock D. N., Moore S., To L. B., Hughes T. P. Peripheral blood is a source of bcr-abl-negative pre-progenitors in early chronic phase chronic myeloid leukemia. Leukemia 1997; 11: 581–587
   PubMed Web of Science ®Google Scholar
• Parkman R., Weinberg K. I., Kapoor N., Franklin J., Yu X. J., Tsark E., Kerkoff K., Smogorzewska E. M., Shah A. J., Crooks G. M. Transplantation with positively selected hematopoietic stem cells (CD34+, CD38-). Exp. Hematol 1997; 25: 261
   Web of Science ®Google Scholar
• Dunbar C. E., Emmons R. V. Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cells 1994; 12: 563–576
   PubMed Web of Science ®Google Scholar